Banka Bioloo (BANKA)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Promoter holding of 52.20% suggests insider alignment with shareholders.
• Sales growth of 8.69% shows some business expansion, even if modest.
• Piotroski F-Score of 6/9 indicates moderate fundamental health across select metrics.
• Book value per share of ₹28.23 provides an asset base, though at a premium price.

Concerns

• Negative ROCE of -7.61% means capital is not being productively employed.
• P/E of 0.00 and net profit near ₹0 Cr in the latest quarter indicate no real earnings.
• Debt/Equity of 1.06 adds financial risk, especially given negative returns on capital.
• P/B of 2.55 is expensive for a company with no return on equity.

AI Analysis

Let me look at Banka Bioloo. At ₹72, the market cap is ₹63 Cr. I see a book value of ₹28.23, so I'm paying 2.55 times book. But what do I get for that? Returns on capital are negative at -7.61%. In other words, the enterprise is destroying value. Sales grew 8.69% last year, but to what end? The latest quarterly net profit is essentially ₹0 Cr. The reported profit growth of 89.73% is meaningless when starting from a base near zero. Debt to equity is 1.06, so there is leverage, but it is not generating a positive return. The Piotroski score of 6/9 is moderate, but not enough to offset poor economics. Promoter holding at 52.20% is decent and aligns interests, but good operators can still run bad businesses. No dividend; I have to rely on price appreciation, which is risky. The 52-week range shows the stock went from ₹41 to ₹97.88, so it has been speculative. As Graham would say, price is what you pay, value is what you get. Here I'm paying a premium to book for a company that cannot earn its cost of capital. I need a margin of safety. This looks like a potential turnaround situation, but I don't see evidence of a sustainable moat or improving returns. I would wait for clear proof of profitability and positive ROCE before putting any money here.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer